相关实验视频

Updated: Jul 25, 2025

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

在地理性缩的第三阶段临床试验的方法评估

Marc Biarnés¹, Xavier Garrell-Salat^1,2, Alba Gómez-Benlloch^1,2

¹OMIQ Research, Carrer de Pedro i Pons 1, 08195 Sant Cugat del Vallès, Spain.

|June 28, 2023

概括

佩格塞塔科普兰是治疗地理缩 (GA) 的第一个疗法,这是导致失明的主要原因. 本综述批判性地评估了GA临床试验的方法,为更好地解释结果提供了见解.

科学领域:

眼科医生眼科眼科
临床试验方法论临床试验方法论
视网膜疾病视网膜疾病

背景情况:

地理缩 (GA) 是全球视力损失的重要原因.
最近批准佩格西塔科普兰标志着GA治疗的里程碑.
对临床试验方法的批判性评估对于了解治疗疗效至关重要.

研究的目的:

批判性地评估地理缩的第三阶段临床试验的方法方面.
分析这些试验的设计,分析和解释.
增强对 GA 中临床试验结果的理解和解释.

主要方法:

从2023年5月起,在公共数据库中注册的GA第三期临床试验的系统审查.
对关键试验属性的分析,包括终点,资格,统计方法和报告.
在五项主要试验 (GATHER1,DERBY/OAKS,CHROMA/SPECTRI,西雅图,GATE) 中方法上的相似性和差异的比较.

主要成果:

已经有五项第三期试验 (GATHER1,DERBY/OAKS,CHROMA/SPECTRI,西雅图,GATE) 报告了结果.
试验在终点和资格方面具有相似之处,但在主要终点指标和样本大小等关键方面有所不同.
方法的变化可能会影响试验结果及其解释.

结论:

了解临床试验方法对于准确解释GA治疗数据至关重要.
作者应遵循报告准则,以透明地沟通试验的进行和结果.
标准化报告和方法考虑对于推动GA研究和治疗至关重要.

关键词:

与年龄相关的黄斑变性.临床试验是指临床试验中的临床试验.终点终点终点终点地理缩是地理上的缩.统计统计统计统计统计

更多相关视频

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Using Retinal Imaging to Study Dementia

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

相关概念视频

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...